Clinical Trial Update: An Observational Study Called ROVER to Learn More About How Well Vericiguat Works in People Who Were Newly Treated With Vericiguat in Routine Medical Care in Germany

View source ↗

Summary

ROVER is an observational study assessing real‑world effectiveness of vericiguat in patients newly treated for chronic heart failure with reduced ejection fract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Vericiguat (vericiguat)

Snippet

Sponsor: Bayer | Conditions: Chronic Heart Failure With Reduced Ejection Fraction | Status: COMPLETED